While there are multiple regulators that have been identified, such as tumour-associated macrophages and myeloid-derived suppressor cells, in the context of ACT, a concerning mediator of the tumour microenvironment is CD4+ Tregs, which have been characterized as CD4+FOXP3+CD25+ [72]. The gene discussed is FOXP3; the disease is neoplasm.